Identification of RP-6685, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ

MLA

Monica Bubenik, et al. “Identification of RP-6685, an Orally Bioavailable Compound That Inhibits the DNA Polymerase Activity of Polθ.” Journal of Medicinal Chemistry, vol. 65, Sept. 2022, pp. 13198–215. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.2c00998.

APA

Monica Bubenik, Pavel Mader, Philippe Mochirian, Fréderic Vallée, Jillian Clark, Jean-François Truchon, Alexander L. Perryman, Victor Pau, Igor Kurinov, Karl E. Zahn, Marie-Eve Leclaire, Robert Papp, Marie-Claude Mathieu, Martine Hamel, Nicole M. Duffy, Claude Godbout, Matias Casas-Selves, Jean-Pierre Falgueyret, Prasamit S. Baruah, … Michel Gallant. (2022). Identification of RP-6685, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ. Journal of Medicinal Chemistry, 65, 13198–13215. https://doi.org/10.1021/acs.jmedchem.2c00998

Chicago

Monica Bubenik, Pavel Mader, Philippe Mochirian, Fréderic Vallée, Jillian Clark, Jean-François Truchon, Alexander L. Perryman, et al. 2022. “Identification of RP-6685, an Orally Bioavailable Compound That Inhibits the DNA Polymerase Activity of Polθ.” Journal of Medicinal Chemistry 65 (September): 13198–215. doi:10.1021/acs.jmedchem.2c00998.